Advertisement

Topics

Avantogen Oncology Company Profile

16:48 EDT 17th August 2018 | BioPortfolio

Avantogen Limited is a drug development Company whose current activities are focused on its three product candidates, namely, RP101 (a potential therapy for pancreatic cancer), GPI-0100 (vaccine adjuvants) and Pentrys™ (cancer vaccine). The Company is currently overseeing Phase II human testing of RP101 in Germany, Phase I human testing of GPI-0100 in the U.S and Phase II human testing of the Pentrys™ cancer vaccine in Australia. In addition, licensing partnerships are being sought by the Directors in respect of the Company's product line of medical nutritionals, Revisys™. Whilst the Company was capable of continuing its product development activities for each of these programs, the Directors decided to restructure both of the Vaccine and Oncology Businesses which would allow the Company to further streamline its activities whilst retaining the significant potential of each product candidate. Merging these products with Hawaii Biotech, Inc and Innovate Oncology, Inc has opened new business potentials leveraging upon the significant experience and expertise these companies have in these respective fields. The final signing of both these formal agreements took place in May 2006.

Location

2121 Avenue of the Stars, Suite 2550
Los Angeles
90067
United States of America

Contact

Phone: (310) 552-2001
Fax: (310) 772-0538
Email: shareholderinfo@avantogen.com


News Articles [395 Associated News Articles listed on BioPortfolio]

Ockham Oncology’s CSO highlights global strength of fully integrated company.

Ockham Oncology’s Chief Scientific Officer Clare Wareing, PhD recounts the companies history and emphasizes complementary strengths that add value following the combination of Ockham Oncology and Ne...

Analysis of oncology pipeline

Oncology research, which includes the medical, radiation, and surgical fields, is always ongoing. Therefore, the oncology pipeline is a key...Read More... The post Analysis of oncology pipeline appear...

Axel Hoos, GSK: Focusing on immuno-oncology and cancer epigenetics

GSK has had a recent change in Oncology after recently divesting their marketed oncology products to Novartis whilst retaining their R&D pipeline. During BIO 2015, Axel Hoos, VP Oncology R&D at GSK ex...

ASCO endorses the integration of quackery into breast cancer care

In 2014, the Society for Integrative Oncology first published clinical guidelines for the care of breast cancer patients. Not surprisingly, SIO advocated "integrating" dubious therapies with oncology....

'Tremendous Loss' of a Giant in Psycho-Oncology

Dr Mark Kris pays tribute to a true giant in the field of oncology and his dear friend, Jimmie Holland. Medscape Oncology

'Moving the Needle' in Oncology Workforce Diversity

Authors of a recent ASCO statement on diversity discuss their experiences and suggestions for improving inclusivity in the oncology workforce. Medscape Oncology

Immuno-Oncology Conference 2018

26 - 27 September, London, UK. Immuno-Oncology is a fast-paced field with massive potential to deliver successful and durable cancer therapies. SMi's Immuno-Oncology Conference will focus on a few key...

Shire announces sale of oncology business to Servier for $2.4 billion

Oncology business provides Servier with an immediate presence in the US, enhancing its commitment to addressing unmet patient needs in oncology

PubMed Articles [1279 Associated PubMed Articles listed on BioPortfolio]

Nonspecialty Nurse Education: Evaluation of the Oncology Intensives Initiative, an Oncology Curriculum to Improve Patient Care.

A community hospital combined its medical and surgical patients with cancer on one unit, which resulted in nurses not trained in oncology caring for this patient population.

Development of a Virtual Radiation Oncology Clinic for training and simulation of errors in the radiation oncology workflow.

The State of Oncology Practice in America, 2018: Results of the ASCO Practice Census Survey.

To describe the US hematology and medical oncology practice landscape and to report findings of the sixth annual ASCO Oncology Practice Census survey.

American Society of Clinical Oncology Statement: Biosimilars in Oncology.

As many biosimilars come to market in the next several years, their use in oncology will play an important role in the future care of patients with cancer. ASCO is committed to providing education and...

Improving Pain Assessment and Management in Routine Oncology Practice: The Role of Implementation Research.

Clinical Trials [504 Associated Clinical Trials listed on BioPortfolio]

Examining Patient Preferences About the IBM Watson Oncology Clinical Decision Support System

The purpose of this study is to learn what cancer patients think about IBM Watson Oncology. IBM Watson Oncology is a computer program designed to help inform oncologists about the best che...

Support of the Sexual Health in Oncology

Implementation of sexual health support program in oncology department. This program is organized in 3 axes. One is to inform the side effects of treatment on sexual health. There is a co...

Clinical Concordance Study Between Watson for Oncology and Clinician Practice

At present, Watson for Oncology has been applied in 14 countries worldwide, including China, the United States, Holland, Thailand, India, Korea, Poland, Slovakia and Bangladesh. In a doubl...

Osteopathic Manipulative Treatment in Oncology Patients' Management

The aim of present study was to study the osteopathic manipulative effects on pain relief and quality of life improvement on hospitalized oncology geriatric patients. A non-randomized comp...

Survivorship Care Plans in a Community Oncology Practice

This is a two part observational study evaluating the feasibility of implementing an EHR-based model within a community oncology practice.

Companies [724 Associated Companies listed on BioPortfolio]

Avantogen Oncology

Avantogen Limited is a drug development Company whose current activities are focused on its three product candidates, namely, RP101 (a potential therapy for pancreatic cancer), GPI-0100 (vaccine adjuv...

Takeda Oncology

Takeda Oncology, headquartered in Cambridge, MA, delivers novel medicines to patients with cancer worldwide through its commitment to science, breakthrough innovation and passion ...

OncLive

OncLive is the official website for Intellisphere’s Oncology Specialty Group, which publishes Oncology & Biotech News, OncologyLive, Oncology Nursing News, and Contemporary O...

Cold Spring Publishing, LLC

Cold Spring Publishing, LLC, (CSP) is a medical publishing company whose principals have more than 50 years of combined publishing experience, with a specific focus in oncology. CSP publishes JNCCN --...

Michiana Hematology-Oncology,P.C.

Michiana Hematology-Oncology,P.C. is the premier provider of medical oncology, gynecologic oncology and adult hematology services in North-Central Indiana and Southwestern Lower Michigan.Michiana Hema...

More Information about "Avantogen Oncology" on BioPortfolio

We have published hundreds of Avantogen Oncology news stories on BioPortfolio along with dozens of Avantogen Oncology Clinical Trials and PubMed Articles about Avantogen Oncology for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Avantogen Oncology Companies in our database. You can also find out about relevant Avantogen Oncology Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Pancreatitis
Pancreatitis Acute pancreatitis is inflammation of the pancreas caused by the release of activated pancreatic enzymes. Common triggers are biliary tract disease and chronic heavy alcohol intake.  Diagnosis is based on clinical presentation...

Head and neck cancers
Cancer can occur in any of the tissues or organs in the head and neck. There are over 30 different places that cancer can develop in the head and neck area. Mouth cancers (oral cancers)  - Mouth cancer can develop on the lip, the tongue, the floor...


Corporate Database Quicklinks



Searches Linking to this Company Record